A Phase 2b/3 Double-Blind, Randomized, Placebo-Controlled Study to Evaluate the Efficacy and Safety of MK-1654 in Healthy Pre-Term and Full-Term Infants
Lay Description
Category
- Healthy Subjects Needed
- Child Health
- Wounds and Injuries
- IRB Number
- 20200668HU
- NCT Number
- ct.gov registration not required
- Open to Enrollment
- Yes
Eligibility
- Eligible Ages
- Eligible Genders
- Accepts Healthy Volunteers
Inclusion Criteria
Exclusion Criteria
Study Design
Arm Groups
Study Contact
Diana Anzueto Guerra
(210) 567-5225
anzuetod@uthscsa.edu
Michael Odom
(210) 567-5186
odom@uthscsa.edu
Diana Anzueto Guerra
(210) 567-5225
anzuetod@uthscsa.edu
Principal Investigator
Michael Odom